Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31]

NCT00081835 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT00081835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00081835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31]
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 2
Overall status
Completed
Start date
April 19, 2004
Completion date
August 15, 2007
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaccinia